Is BNOX or QYLD a better dividend investment in 2026?

BNOX currently yields 790.20% with a 5% 5-year dividend growth rate. QYLD yields 11.92% with -2.1% growth. The better choice depends on your goal: BNOX offers higher current income.

What is the dividend yield difference between BNOX and QYLD?

BNOX has a forward dividend yield of 790.20% ($2.00/share annually). QYLD yields 11.92% ($2.04/share annually). The yield gap is 778.28 percentage points.

Home › Compare › BNOX vs QYLD

BNOX vs QYLD: Dividend Comparison 2026

BNOX yields 790.20% · QYLD yields 11.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BNOX wins by $2499878.55M in total portfolio value

INVESTMENT

TIME HORIZON10 years

BNOX

● Live price

790.20%

Share price

$0.25

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2499878.58M

Annual income

$2,001,595,404,407.55

Full BNOX calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

11.92%

Share price

$17.15

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.4K

Annual income

$5,659.31

Full QYLD calculator →

Portfolio growth — BNOX vs QYLD

📍 BNOX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BNOX	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BNOX + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BNOX pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BNOX

Annual income on $10K today (after 15% tax)

$67,167.13/yr

After 10yr DRIP, annual income (after tax)

$1,701,356,093,746.42/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,013.51/yr

After 10yr DRIP, annual income (after tax)

$4,810.41/yr

At 15% tax rate, BNOX beats the other by $1,701,356,088,936.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BNOX + QYLD for your $10,000?

BNOX: 50%QYLD: 50%

100% QYLD50/50100% BNOX

Portfolio after 10yr

$1249939.30M

Annual income

$1,000,797,705,033.44/yr

Blended yield

80.07%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BNOX buys

QYLD buys

No recent congressional trades found for BNOX or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBNOXQYLD

Forward yield	790.20% ✓	11.92%
Annual dividend / share	$2.00	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$2499878.58M ✓	$25.4K
Annual income after 10y	$2,001,595,404,407.55 ✓	$5,659.31
Total dividends collected	$2460392.87M ✓	$27.1K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: BNOX vs QYLD ($10,000, DRIP)

Year	BNOX Portfolio	BNOX Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$89,720	$79,020.15	$10,352	$1,192.36	+$79.4K → BNOX
2	$758,589	$662,588.76	$10,830	$1,347.57	+$747.8K → BNOX
3	$6,047,418	$5,235,727.31	$11,460	$1,539.07	+$6.04M → BNOX
4	$45,478,990	$39,008,252.73	$12,275	$1,777.84	+$45.47M → BNOX
5	$322,828,490	$274,165,970.92	$13,323	$2,078.95	+$322.82M → BNOX
6	$2,164,251,074	$1,818,824,589.26	$14,667	$2,463.34	+$2164.24M → BNOX
7	$13,711,496,364	$11,395,747,714.83	$16,396	$2,960.57	+$13711.48M → BNOX
8	$82,145,270,460	$67,473,969,350.51	$18,631	$3,612.97	+$82145.25M → BNOX
9	$465,685,208,688	$377,789,769,296.29	$21,548	$4,482.15	+$465685.19M → BNOX
10	$2,499,878,577,704	$2,001,595,404,407.55	$25,398	$5,659.31	+$2499878.55M → BNOX

BNOX vs QYLD: Complete Analysis 2026

BNOX — Stock

Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which has completed phase 2 clinical trial for the treatment of social anxiety disorder and post-traumatic stress disorder. It also develops BNC375, a small molecule therapeutics for the treatment of cognitive impairment in Alzheimer's disease; BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, a vascular disrupting agent, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer, and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. Bionomics Limited has a licensing agreement with Merck & Co., Inc. The company was incorporated in 1996 and is based in Eastwood, Australia.

Full BNOX Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this BNOX vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BNOX vs SCHD BNOX vs JEPI BNOX vs O BNOX vs KO BNOX vs MAIN BNOX vs XYLD BNOX vs JEPQ BNOX vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.